Purpureocillium lilacinum, previously classified as Paecilomyces lilacinus, is a ubiquitous hyaline hyphomycete considered to be an emerging opportunistic human pathogen that is resistant to traditional antifungal agents. This case report describes what is to our knowledge the only published case of P. lilacinum recrudescence in an immunocompetent host despite initial best-practice treatment with 10 weeks of voriconazole and surgical excision.
Keywords: Paecilomyces lilacinus; Purpureocillium lilacinum; anti fungal agents; cutaneous hyalohyphomycosis; dermatology; human; immunocompetent; posaconazole; voriconazole.
© 2021 The Australasian College of Dermatologists.